TECHNEUTRAL

Return on Equity (ROE)

5.3%

Higher than 43% of Healthcare sector peers

Updated 28h ago

Sector Performance

43th percentile

TECH

5.3%

Sector Median

8.9%

Sector Avg

37.1%

📊

Deep Analysis

Return on Equity (ROE) measures how much profit a company generates for each dollar of shareholders’ equity — a 5.3% ROE means Bio-Techne earned $0.053 for every $1 of equity.

That return places the company below the Healthcare sector median of 8.9%, and it sits at the 43rd percentile among its sector peers, indicating weaker profitability relative to the typical competitor. No year-over-year or quarter-over-quarter changes are available, and the most recent single data point shows no trend to evaluate. The combination of a below-median ROE with no observable trend suggests a static level of earnings efficiency, which neither signals a clear improvement nor a deterioration, leaving the risk-return profile muddled. This metric supports the overall NEUTRAL verdict — the ROE is not strong enough to warrant a bullish view, yet it is not alarmingly low enough to justify a bearish stance.

Frequently Asked Questions

What does the Return on Equity (ROE) tell investors about TECH?

ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.

How is the Return on Equity (ROE) calculated?

Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.

How does TECH's Return on Equity (ROE) compare to its sector?

TECH's Return on Equity (ROE) of 5.3% compares to a Healthcare sector median of 8.9%, placing it in the 43th percentile.

Who are TECH's closest peers by Return on Equity (ROE)?

The closest Healthcare peers by Return on Equity (ROE) include: BIIB (7.7%), ZBH (6.1%), TMO (13.5%), RVTY (3.2%), BIO (2.5%).

The Formula

Net Income / Shareholders' Equity

Why It Matters

ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.